Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial

Stepped dose titration improved tolerability.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/amylin-analog-eloralintide-reduces-weight-phase-2-trial-2025a1000uqf?src=rss

Author :

Publish date : 2025-11-06 21:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Amylin Analog Eloralintide Reduces Weight in Phase 2 Trial

FDA Broadens Caplyta Approval to Include Major Depression

SDPA President Reflects on 2025 Highlights

Related Posts

Patient-Reported Skin Changes After GLP-1 Use Explored

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Patient-Reported Skin Changes After GLP-1 Use Explored

Biomass Cooking Pollution Not Linked to Pneumonia in Infants

Automatic Doors May Raise Risk for Injury Among Older Adults

GLP-1 RAs Effective for Weight Loss in T1D and Obesity

Remibrutinib for CSU Shows Sustained Efficacy at 1 Year

Kissing may have evolved in an ape ancestor 21 million years ago

Sesame Allergy Study Compares Oral Food Challenge Methods

What’s in the New Settlement Against OxyContin-Maker Purdue and the Sackler Family

Categories

Archives